Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc., which is a subsidiary) on May 26, 2010. The filing details executive compensation adjustments, including a new fiscal year 2011 cash bonus plan and specific equity grants and salary increases for named executive officers.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on compensation structures and executive remuneration.
Material Changes and Compensation Details
2011 Fiscal Year Cash Bonus Plan
- Approved May 28, 2010, for employees of Landec, Apio, Inc., and Lifecore Biomedical, Inc.
- Bonuses are based on separate revenue and operating income targets for each entity.
- Maximum bonus percentages range from 40% to 104% of base salary for executives and 8% to 40% for other employees.
- Eligibility requires employment through the end of fiscal year 2011.
Executive Equity Grants (May 26, 2010)
| Officer | Title | Stock Options | Restricted Stock Units (RSUs) |
|---|---|---|---|
| Steve Bitler | V.P. of Corporate Technology | 45,000 | 15,000 |
| David Taft | Chief Operating Officer | 60,000 | 20,000 |
| Gregory Skinner | Chief Financial Officer | 75,000 | 25,000 |
| Gary Steele | Chief Executive Officer | 75,000 | 25,000 |
Note: Options vest monthly over three years; RSUs vest on the third anniversary.
Executive Salary Increases
| Officer | 2010 Base Salary | 2011 Base Salary | Effective Date |
|---|---|---|---|
| Steve Bitler | $205,000 | $220,000 | June 1, 2010 |
| David Taft | $300,000 | $325,000 | June 1, 2010 |
| Gregory Skinner | $265,000 | $310,000 | June 1, 2010 |
| Gary Steele | N/A | $450,000 | January 1, 2011 |
Additional Grants
On May 28, 2010, Ron Midyett (CEO of Apio) received an option to purchase 67,000 shares and an award of 22,333 RSUs.
Guidance, Outlook, and Risks
The filing contains no financial guidance, market outlook, or discussion of risks and contingencies. The primary contingency noted is that bonus payments are contingent upon employees remaining with the company through the end of fiscal year 2011.
Key Facts for Investor Verification
- Confirm the registrant is Landec Corporation, with Lifecore Biomedical listed as a subsidiary.
- Verify the vesting schedules for the newly granted stock options and RSUs.
- Review the specific revenue and operating income targets set for the 2011 bonus plan, which are not detailed in this filing.
- Note the significant salary increase for CEO Gary Steele effective January 1, 2011, as per his employment agreement.